Gonorrhea Diagnostic Market size , share and forecast upto 2024

Ease of Testing: Can be done on non-invasive and self-collected specimens

Sexually transmitted Diseases (STDs) are one of the leading health problems globally, affecting the quality of life and triggering serious morbidity and mortality. Gonorrhea is the most common among the various sexually transmitted diseases with the age group of 15 to 24 years being the largest affected group. Around 350,062 gonorrhea cases were reported in the U.S. in 2014, with the national gonorrhea rate increasing to 110.7 cases per 100,000 population. There are major complications when infected with sexually transmitted infections, which have a detrimental effect on the reproductive system and can adversely affect health of the child conceived by an infected mother. Infertility, cancers, and pregnancy complications are among the major complications that can arise from the disease. Symptoms of gonorrhea in men include painful urination, swelling of testicles and pus discharge. In women, symptoms encompass excessive vaginal discharge, painful urination, and abdominal pain. Various complications such as ectopic pregnancy, Pelvic Inflammatory Disease (PID) and Epididymitis are most common among females.

Request Sample of Gonorrhea Diagnostic Market: https://www.coherentmarketinsights.com/insight/request-sample/126

Thus, these complications further indirectly impact through facilitating sexual transmission of deadly virus such as human immunodeficiency virus (HIV) and therefore, it also significantly adds to disease burden. In 2012, approximately 357 million new cases of curable STIs (gonorrhea, chlamydia, syphilis and trichomoniasis) were reported worldwide, which include 78 million cases of gonorrhea occurring at the age group of 15–49 year-olds. More than a million Sexually Transmitted Infections are acquired every day of which around 50% infections turn into Sexually Transmitted Diseases.

Uncomplicated Gonorrhea: Developing Drugs for Treatment

Factors driving growth of the gonorrhea diagnostic market include increase in transmission of sexually transmitted infection. For instance, according to Centers for Disease Control and Prevention data on STD Surveillance Report, in 2013, there were around 1.4 million reported cases of chlamydia, a rate of 456.1 cases per 100,000 population and in 2014, there were 350,062 reported cases of gonorrhea (a rate of 110.7 per 100,000) in the U.S.  Lack of biomedical products is a serious factor contributing to high incidence rate of STDs in low income countries. For instance, estimates by the International Conference on Population and Development (2011), for Sub-Saharan Africa, indicates that only nine organizations donated condoms per year to people in the age group of 15–49-years and that only one female condom per year is available for every 10 women of the same age range. Condom supplies in many high-burden countries are still inadequate. Lower treatment cost for the test, where STI prevention counseling and HIV screenings are some of many free preventive care benefits under the Affordable Care Act, though the tests themselves may cost you. In the U.S., private health centers charge up to US$ 79 for individual STI tests and US$ 249 for comprehensive STI tests. The Florida Department of Health, for instance, charges only $45 for its comprehensive STI test. However, lack of STI prevention counselling and dearth of trained laboratory specialists are some of the factors restraining growth of the global gonorrhea diagnostics market.

Artificial intelligence and diagnostic imaging are in the testing phases and expected to dominate the gonorrhea diagnostic market

The global gonorrhea diagnostic market is segmented on the basis of diagnostic type, end user, and geography. On the basis of diagnostic type, the gonorrhea diagnostic market is divided into diagnostic imaging, molecular diagnostics, flow cytometry, chromatography, gel micro droplets, liposomes, differential light scattering (DLS), artificial intelligence, and monoclonal antibodies test. Molecular Diagnostic is sub-segmented into Nucleic Acid Amplification Tests (NAAT) and swab tests.

On the basis of end user, the gonorrhea diagnostic market is classified into hospitals, ambulatory surgical centers, diagnostic centers, clinics, and others.

Check The Trending Report Gonorrhea diagnostic market : https://www.coherentmarketinsights.com/ongoing-insight/gonorrhea-diagnostic-market-126

Gonorrhea diagnostic market traction is expected to be fueled by Growing Prevalence of STDs in Asia Pacific

Regional segmentation by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America accounts for the largest market share, mainly due to presence of major players and adoption of advanced medical technologies in countries such as U.S. and Canada. In 2013, according to the U.S. Center for Disease Control and Prevention (CDC) there were over 3.3 million cases of gonorrhea registered. Europe is the second-largest gonorrhea diagnostic market, owing to the increasing prevalence of the disease in the region and largely unmet needs in effective diagnosis and treatments. In 2013, according to European Centre for Disease Prevention and Control, 52,995 gonorrhea cases were reported across 28 countries in the region; 61% of all cases were reported in the U.K. Growing disposable income and increasing awareness levels among the populace in Asia Pacific, along with a large population base is expected to drive the market in Asia Pacific in the near future.

Request the table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/126

Licensing approval: Approved for endocervical, vaginal, urethral, urine specimens

Key players operating the gonorrhea diagnostic market include Becton, Dickinson and Company, Baxter International, Inc., Pfizer Inc., B. Braun Melsungen AG, Fresenius SE & CO. KGaA, Medtronic plc, Smiths Group plc, Terumo Corporation, Moog, Inc., F. Hoffmann-la Roche Ltd., and Johnson & Johnson. Major companies in the market are constantly working towards introducing innovative tests and lower the costs in order to improve patient outcomes and enhance profitability.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights
1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com

Visit Blog : http://globalresearchtrends.blogspot.in

Advertisements

Organ-on-a-chip Market size , share and forecast upto 2024

Organ-on-a-chip Market Overview:

Organ-on-a-chip is gaining prominence on the backdrop of regulatory measures on animal testing and growing complexity in therapeutic applications. Various players are trying to capitalize on lucrative growth opportunities in the organ-on-a-chip devices market. It is a unique cell culture process, wherein biomimetic microsystem is used as a platform.

These devices are built on silicone, which can be used to grow internal organs. This finds application in organ transplantation and also therapeutics. Harvard’s Wyss Institute is engaged in lung-on-chip production, commercialization of which would help in exponential growth of the organ-on-a-chip market. Moreover, partnerships of biotech and pharmaceutical companies with universities is expected to scale up the commercialization process in the near future. This billion dollar industry is expected to create significant market opportunities for players. Some companies such as Mimetas are currently engaged in development of kidney-on-a-chip. This technology is gaining traction as this unique technology greatly reduces the amount of testing carried out on animals, while providing highly accurate results.

Get an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/49

Organ-on-a-chip Market Dynamics

Organ-on-a-chip is expected to cater to wide range of applications ranging from disease modelling to patient stratification and phenotypic screening. Most of the demand is expected to be generated from lung-based organ culture, followed by kidney application. The technology offers better clinical examinations compared to petri dishes and animal testing – helping scientists and companies to better understand the functioning of internal organs such as the brain and lungs.

Funding and government initiatives are projected to further boost market growth in the near future. Though the market is expected to create substantial opportunities, high cost and early stage in R&D are some of the factors leading to slow growth of the market. Market is expected to witness rampant commercialization post-2020.

Organ-on-a-chip Market – Regional Analysis

North America and Europe are expected to dominate the overall organ-on-a-chip market throughout the forecast period. The regions are early adopters of newly developed technology. Moreover, demand is expected to be further propelled by large consumer base in these regions. North America spends over 16% of its GDP on healthcare. Moreover, various research activities are carried out in the region, which is home to some of the leading players in the market. Also, organ transplant rate is high in the region. Growth of the Europe market is expected to be primarily driven by rising demand for organ-on-chip in Germany, U.K., and France.

Asia Pacific is a lucrative market for companies engaged in organ-on-a-chip industry. However, commercialization is not expected to take place in early years. As market is still in its early stage, it would take a few years before companies can expect return on profit. Japan and China are key markets in Asia Pacific. These countries account for over half of the pharmaceutical market in Asia Pacific. Also, these countries are well equipped with technologically advanced medical devices and research centers.

Request for a table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/49

Organ-on-a-chip Market – Competitive Landscape

Organovo, Hepregen, Hurel Corporation, Nortis, TissUse, Tara Biosystems, and AxoSim are some of the players engaged in organ-on-a-chip market. These companies are located in North America, with most being start-ups albeit with major funding and are expected to attain major commercial success in the near future.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Plant Stem Cell Market size , share and forecast upto 2024

Plant Stem Cell Market Overview:

Plant stem cells are undifferentiated cells within the meristems of plants. Plant stem cells serve as the origin of plant vitality as they maintain themselves and provide a steady supply of precursor cells to form various tissues and organs in plants. Plant stem cells are characterized by two distinctive properties namely its ability to create differentiated cell types and to self-renew such that the number of stem cells remain stable. The plant stem cell market focuses on this ability of plant cells and thus, processed extracts from the buds, roots and shoots are in high demand and are widely used for topical uses.

Advancements in technology have led to use of either the regenerated plants developed by plant stem cells or the secondary metabolite created by the single cells during culturing. These have been proven beneficial for skin care and hair growth. Plant cell extracts are obtained through complex cultivation and extraction processes. Most preferred plant sources are alpine rose, grape, Swiss apple, edelweiss, gardenia, lilac, etc. Of these, the Swiss apple and grape are most widely used in the industry. Plant stem cells are more versatile and powerful than the whole plant. Hence, they are used in a wide range of applications. Their totipotent nature makes them a vital compound for various applications. Plant stem cell technology is mainly used in the cosmetics industry for manufacture of various skin and hair, among others.

Fill the form for an exclusive sample of Plant Stem Cell Market report @ https://www.coherentmarketinsights.com/insight/request-sample/98

Growing demand for natural compounds fueling the plant stem cell market growth

Plant stem cell is an emerging industry and growth is constantly spurted by various researches on different plants to explore their potential application in the market. Naturally occurring botanicals having antioxidant levels have the ability of protecting human skin cells from UV-induced oxidative stress and neutralize free radicals. Increase in demand for natural compounds among the populace, acts as a major driver for the plant stem cell market. Plant stem cell cultures with positive results for use in cosmetic industry have offered a wide range of opportunities for skin care and hair treatments that are contaminant free and use bio-sustainable products. Hence, rising demand for anti-aging, hair care, skin care, and other cosmetic products consequently fuel growth of the plant stem cell market.

Segmentation of plant stem cell market on basis of location and application

On the basis of location, the global plant stem cells market can be classified as root apical meristems, shoot apical meristems, and vascular meristems. The root and shoot meristems are the most dominant segments in the market. On the basis of application, the plant stem cell market can be classified as nutrition, pharmaceutical, and cosmetics. In the past, cosmetics and aesthetics were considered to be more women-concentrated fields. However, the potential male cosmetics products segment is an untapped opportunity for the plant stem cell market.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/98

Rise in demand for natural products in North America boost growth of the plant stem cell market

North America and Europe are major market for plant stem cell. The main factor is advanced technology that allows research on cultivation and extraction of components from plants. Also, rising demand for naturally-obtained products among the populace and increasing awareness contributes towards growth of the plant stem cell market in these developed regions. The plant stem cell industry highly dependent on research work. Increasing R&D activities and government funding is positioning Asia Pacific as a hub for research activities, in turn making it a potential market for plant stem cell.

Key players engaged in plant stem cell market

Some of the major players in the market are Oriflame Holding AG, MyChelle Dermaceuticals, LLC, Natura Therapeutics Inc, Aidan Products LLC, Mibelle Biochemistry, Phyto Science SDN BHD, and Renature Skin Care Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Gynecological Examination Chairs Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

The Gynecological Devices Market was valued at US$ 2,667.8 million in 2015 and is projected to expand at a CAGR of 6.3% during the forecast period (2016–2024),as highlighted in a new report published by Coherent Market Insights.Increasing incidence of gynecological disorders is projected to favor the growth for gynecological devices market in the near future.

Around 10% of the global female population is affected by endometriosis according to the estimates by Endmoetriosis UK (2016). Risk of gynecological disorders increases with age. According to the World Bank, female population aged 65 years and above increased exponentially from 6.8% in 2010 to 8.2% in 2015. Furthermore, changing lifestyle habits and risk of infection is expected to result in high incidence of gynecological disorders. The outlook for the gynecological devices market is therefore bright in the foreseeable future.

Get Discount On This Report: https://www.coherentmarketinsights.com/insight/request-discount/152

Safety is one of the major concerns of healthcare practitioners using gynecological devices. Bayer’s Essure is an intra-uterine device (IUD) that has been linked with skin rashes and pelvic pain in women (in the U.S.) who have inserted it as a permanent contraceptive solution. This has led women to remove the Essure through surgery. The U.S. FDA has called for a black box warning for the device. Furthermore, the FDA has also asked manufacturers of power morcellators to mention a warning that the product ‘has not been proved to reduce the risk of spreading cancer’. Power morcellators are used to dissect and remove uterus or uterine fibroids through small incisions. However, these devices are reported to cause uterine cancer, which remain undetected owing to lack of awareness.

Post-surgical complications are among the most frequent complications in abdominopelvic surgery. Endometriosis and infection in pelvic region can stimulate the formation of adhesions, which may lead to discomfort, chronic pain and infertility. Actamax Surgical Materials LLC (subsidiary of DSM Biomedical), submitted an Investigational Device Exemption (IDE) to the U.S. FDA in February 2017 for its Actamax adhesion barrier to be utilized in in gynecological laparoscopic surgery. Such innovative solutions for the existing concerns on the gynecological surgeries would favor the growth of gynecological devices market globally.

Request sample of Gynecological Devices Market: https://www.coherentmarketinsights.com/insight/request-sample/152

Being a very intimate category of devices, safety is therefore the priority for users. Manufacturers need to gather enough evidences of safety and efficacy to avoid post-marketing recalls and regulatory hurdles. Specialized speculums, curettes, and forceps ease the surgical procedures. Demand for gynecological chairs is expected to grow rapidly during the forecast period as hospitals upgrade their infrastructure, especially in emerging economies such as India, China, and Brazil.

Key takeaways of the market:

  • The global gynecological devices market is expected to expand at a CAGR of 6.3% during the forecast period (2016–2024). Rise in number of gynecological surgeries is expected to favor the growth of gynecological devices market in the near future.
  • Surgical devices is expected to dominate the market throughout the forecast period as these devices are in regular demand for gynecological surgeries
  • Demand for gynecological chairs is projected to grow gradually with growing investment in infrastructure upgradation and establishment of new surgical and gynecological examination rooms
  • Gynecological devices market in the Asia Pacific region would be growing rapidly with increasing incidence of gynecological disorders and the number of gynecological surgeries
  • Hospital are the major users of gynecological devices and would be driving the global gynecological devices market
  • Major market payers including Ethicon, Inc., Hologic, Inc., Stryker Corporation, Cooper Surgical, Inc., Karl Storz GmbH& Co. KG, Boston Scientific Corporation, and Richard Wolf GmbH need to consider the safety of deices to avoid any post-marketing issues
  • These players can opt for emerging nations for a rapid growth in business expansion

    To know the latest trends and insights prevalent in the gynecological devices market, click the link below:

    https://www.coherentmarketinsights.com/market-insight/gynecological-devices-market-152

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah

Coherent Market Insights
1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com/

Visit Blog : http://globalresearchtrends.blogspot.in/

Global Respiratory Inhalers Market Size and Forecast, US$ Million and Y-o-Y Growth (%), 2014–2024

The global respiratory inhalers market was valued at US$ 25,846.7 million in 2015 and is projected to expand at a CAGR of 4.2% during the forecast period (2016–2024), as highlighted in a new report Global Respiratory Inhalers Market, By Devices (Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers), Technology (Digital, Manual), Therapeutic Application (Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Arterial Hypertension), and Geography – Insights, Opportunity Analysis, and Industry Forecast till 2024″ published by Coherent Market Insights. High prevalence of respiratory diseases, rapid growth of the aging population, and large number of smokers are expected to be major factors driving growth of the global respiratory inhalers market over the foreseeable future.

Chronic obstructive pulmonary disease (COPD) is a life-threatening disease affecting the lungs characterized by acute breathlessness. In 2015, it is estimated that around 3 million deaths occurred due to sever Chronic Obstructive Pulmonary Disease, with 90% fatalities reported in low and middle income countries. The major reason for chronic obstructive pulmonary disease is exposure to tobacco smoke through active or passive smoking. Most chronic obstructive pulmonary disease cases are preventable by avoiding tobacco smoking. However, countries need to adopt the WHO Framework Convention on Tobacco Control (WHO-FCTC) and follow the MPOWER package of measures so that non-smoking becomes the norm globally.

Asthma is also one of the prime conditions leading to respiratory, disease which is characterized by recurring attacks of panting and wheezing. The severity and frequency of asthma varies according to individual. According to the American Academy of Allergy, Asthma & Immunology, approximately 250,000 people die each year from asthma. Around 100 million people are expected to suffer from asthma by 2025. According to National Center for Health Statistics, asthma prevalence among all adults was reported at 8.8% in 2014.

To know the latest trends and insights prevalent in the Respiratory Inhalers Market, click the link below:

https://www.coherentmarketinsights.com/insight/request-sample/227

According to Centers for Disease Control, 10 fatalities are caused due to asthma in the U.S. each day, with 3,651 deaths reported in 2014. Of these, 20-30% of asthma cases were avoidable through proper treatment and care. Women accounted for 65% deaths, with African-American women at higher risk. According to Centers for Disease Control and Prevention, the annual economic burden costs over US$ 56 billion.

Inhalers play a pivotal role in treatment of asthma and chronic obstructive pulmonary disease. The importance of the inhalation is delivery of medicines that directly acts on air passage and lungs. This signifies the higher concentrations of drug at target site, with lower systemic exposure thus also have low adverse effects than the oral or intravenous administration of drug. The drawback of inhalers are that it leads to suboptimal use and low efficacy. The design of the inhalers also plays an important role in drug deposition, the characteristics of the inhaled medicine, and on the ability of the patient to use the device.

Key takeaways of the respiratory inhalers market:

  • The global respiratory inhalers market is expected to expand at a CAGR of 2% during the forecast period (2016–2024) as there exists a huge unrealized market especially in Asia Pacific, Latin America, Middle East and Africa

  • Manually segment is expected to dominate the market throughout the forecast period, with a market share of about 91% in 2016

  • Asthma, a therapeutic application segment is expected to dominate the market throughout the forecast period with increasing prevalence of asthma

Get an exclusive discount on this report: https://www.coherentmarketinsights.com/insight/request-discount/227

  • Some of the major players involved in global respiratory inhalers market are AstraZeneca, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc, Koninklijke Philips N.V., Merck & Co., Inc., OMRON Healthcare Europe B.V., PARI Medical Holding and Teva Pharmaceutical Industries Ltd.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com

Implantable Cardioverter-defibrillators Market size , share and forecast upto 2024

Implantable Cardioverter-defibrillators Market Overview:

An ICD or implantable cardioverter-defibrillator is a battery-operated device that is placed under the skin of the patient to monitor the user’s heart rate. ICDs are connected to the heart by thin wires. In cases where an abnormal heart beat is detected, implantable cardioverter-defibrillator deliver an electric shock to reinstate a normal heart rhythm if the patient’s heart is beating too fast. Implantable cardioverter-defibrillators have been useful in thwarting sudden deaths in patients with fibrillation or sustained ventricular tachycardia. Various studies have shown that they may prevent cardiac arrest in patients who are at a high risk of life-threatening ventricular arrhythmias. An implantable cardioverter -defibrillator senses when the heart rhythm is not normal and it tries to make the heart rhythm normal. If the device has a pacemaker feature incorporated, it works as a pacemaker when the heartbeat is slow, and transmit tiny electric signals to the heart. However, when the heartbeat is very chaotic or fast, the device gives defibrillation shocks in order to restrain the abnormal rhythm. Implantable cardioverter-defibrillators work for 24 hours a day.According to Centers for Disease Control and Prevention (CDC), it is estimated that around 2.7–6.1 million individuals in the U.S. suffered from atrial fibrillation in 2015. The report suggests that the number of occurrences is likely to increase with the increase in number of aging of the population in this region. Roughly 2% of the population who are younger than 65 years of age suffers from AF. However, around 9% of the population with 65 years of age or more suffers from AF. Increasing cases of AF among the global population coupled with advancement in technology will drive the implantable cardioverter-defibrillators market during the forecast period.

Request the sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/223

Implantable Cardioverter-defibrillators Market Taxonomy

On the basis of type of product, the global market is classified into:

  • Biventricular Implantable Cardioverter Defibrillators

  • Single Chambered

  • Dual Chambered

On the basis of type of procedure, the global market is classified into:

  • Subcutaneous Implantable Cardioverter Defibrillators

  • Trans-Venous Implantable Cardioverter Defibrillators

On the basis of end user, the global market is classified into:

  • Hospitals

  • Specialty Clinics

  • Ambulatory Surgical Centers

  • Others

The subcutaneous ICD (S-ICD) is inserted without placing the leads into the heart. The device is inserted below the left axilla, or armpit in line with the rib cage. The lead connected to the device is laired under the skin more willingly than inside the heart. Some of the advantages of the S-ICD are the lack of immediate or long-term complications caused by inserting a lead into the heart, such as collapse of the lung and perforation of the heart. Subcutaneous implantable cardioverter defibrillators are the main driver for the global ICD market due to the aforementioned reasons. The rise in adoption of S-ICDs will propel the overall implantable cardioverter-defibrillators market in the forecast period.

High prevalence of arrhythmia will drive the overall implantable cardioverter-defibrillators market

The rising old age population and high occurrence of coronary artery diseases are some of the major factors which will propel growth of the implantable cardioverter-defibrillators market. Sedentary lifestyles, unhealthy dietary habits, and lack of proper exercise have resulted into the increased incidences of heart related diseases, especially arrhythmia. The demand for ICDs is rising significantly as healthcare professionals and the governing bodies such as American Heart Association have widely accepted this form of treatment due to its safety, and efficacy. However, the AHA recommends that the arrhythmia in question ought to be life threatening for the patient to be eligible for a cardioverter defibrillator.

North America held the maximum market share in implantable cardioverter defibrillator market globally. Favorable and constructive policies and regulations as well as availability of sophisticated healthcare facilities along with rising approvals about the usage of implantable cardioverter-defibrillators from the governing bodies are likely to fuel the growth of the implantable cardioverter-defibrillators industry in this region.

Request for the table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/223

Some of the key players operating in the global implantable cardioverter-defibrillators market are Imricor Medical Systems, Boston Scientific Corporation, Inc., LivaNova PLC Company, MicroPort Scientific Corporation, Mayo Clinic US, Medtronic plc, St. Jude Medical, Inc., and MRI Interventions, Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights
1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com

Visit Blog : http://globalresearchtrends.blogspot.in

Global 3D Printed Medical Devices Market size, share and forecast upto 2024

3D Printing: Ushering in the New Era of Customized Medical Devices

3D printed medical devices are three-dimensional objects, created by attaching successive layers of objects through a 3D digital file. Such devices are highly customized to suit the patient’s unique needs, which in turn helps provide better patient outcomes. Moreover, it can also be used to develop anatomical models for medical related education and for training purposes. This is a rapidly emerging technology facilitating production of different kinds of medical products such as implants, surgical instruments, and external prosthetics. The process of 3D printed medical device manufacturing involves multiple steps. These steps depend upon the type of printing and the complexity of the equipment.

Fill the form for an exclusive sample of this report @ https://www.coherentmarketinsights.com/insight/request-sample/29

Technological advancements making 3D-printed devices more affordable

Factors driving growth of the 3D printed medical devices market include rising technological advancements through development of innovative 3D printed medical equipment and increasing healthcare spending worldwide. For instance, Stratasys Ltd. is focusing on development of extensive detailed prototypes or molds made of flexible and transparent materials for detailed study of chronic diseases. Moreover, aging population also contributes towards the demand for these devices. This is primarily due to the fact that this particular demographic group is more susceptible to osteoarthritis, gangrene, as a risk of diabetes and chronic heart disorders. Rising incidence of road and other accidents is also expected to influence market growth. However, stringent regulatory framework, high cost of 3D printed devices, and low reimbursement policies are some of the factors restraining market growth for 3D printed medical devices.

Prosthetics and implants the mainstay of 3D-printed medical devices

The global 3D printed medical devices market is segmented on the basis of product type, raw material, technology, end user, and geography. On the basis of product type, the market is segmented into implants, surgical instruments, prosthetics, tissue engineering devices, and others. Implants is sub-segmented into cranial implants, orthopedic implants, and dental implants; surgical instruments is sub-segmented into scalpels, retractors, and others; tissue engineering devices is sub-segmented into bone and cartilage scaffolds and ligament and tendon scaffolds.

On the basis of raw material, the market is divided into plastics, biomaterial inks, and metal and alloys. Plastics are further divided into thermoplastics and photopolymers. Biomaterial inks include polymers, ceramics and hydrogels.

On the basis of technology, the market is segmented into Fused Deposition Modeling (FDM), Digital Light Processing (DLP), Stereolithography (SLA), Selective Laser Melting (SLM), Electron Beam Melting (EBM), Multi Jet Fusion (MJF), and others.

On the basis of end user, the market is classified into hospitals, diagnostic centers, academic institutions, and others.

Burgeoning geriatric population in Europe a highly lucrative market

Regional segmentation by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America accounts for the largest market share, mainly due to presence of major players and early adoption of advanced medical technologies in countries such as U.S. and Canada. Europe is the second-largest market, owing to the large target population, especially comprising of elderly people, with high approval for use of 3D-printed medical devices. Growing disposable income and increasing awareness levels among the populace in Asia Pacific, along with a large population base is expected to position Asia Pacific as a high growth market in the near future.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/29

Stratasys Ltd. is one of the major companies for 3D printed medical devices market

Key players operating the 3D medical devices market include 3D Systems, Inc., Stratasys Ltd., EOS GmbH Electro Optical Systems, Arcam AB, FabRx Ltd., Bio3D Technologies, EnvisionTEC, Cyfuse Biomedical K.K., Concept Laser GmbH, 3T RPD, Ltd., and Prodways. Major companies in the market are constantly working towards introducing innovative products and lower production costs in order to enhance profitability. For instance, in November 2016, 3D Systems extended its anatomical modeling service aimed at including pliable MultiJet Printing (MJP) material for patient-specific 3D modelling and printing services.

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com